COVIRNA session at the European Health Management Association (EHMA) 2021 Annual Conference highlights the role of predictive models in improving patient outcomes
On Wednesday, 15 September, the COVIRNA project hosted a session at the EHMA 2021 Annual Conference titled ‘Towards personalised medicine – an innovative diagnostic tool to identify cardiovascular complications in COVID-19 patients‘. The session examined the benefits of personalised disease management on health systems and discussed how patient-centred care and personalised medicine can improve disease outcomes and enhance patient quality of life. It also looked at some of the most common challenges which arise when sharing data across health institutions and at how AI can be employed to develop predictive models.
Pharmahungary Group is supporting the aims of the COVIRNA project with our innovative bioinformatics tools such as miRNAtarget and our preclinical and clinical R&D expertise.
For more information please see COVIRNA consortium website.